| Adult & Child Neurology Medical Associates Inc. | |
|
2880 Atlantic Ave 260 Long Beach CA 90806-1714 | |
| (562) 490-3580 | |
| (562) 490-3584 |
| Full Name | Adult & Child Neurology Medical Associates Inc. |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2880 Atlantic Ave, Long Beach, California |
| Authorized Official Name and Position | Thanh T Le (TREASURER) |
| Authorized Official Contact | 5624903580 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Adult & Child Neurology Medical Associates Inc. 2880 Atlantic Ave 260 Long Beach CA 90806-1714 Ph: (562) 490-3580 | Adult & Child Neurology Medical Associates Inc. 2880 Atlantic Ave 260 Long Beach CA 90806-1714 Ph: (562) 490-3580 |
| NPI Number | 1013959402 |
|---|---|
| Provider Enumeration Date | 06/12/2006 |
| Last Update Date | 06/10/2015 |
| Medicare PECOS PAC ID | 1355437914 |
|---|---|
| Medicare Enrollment ID | O20071012000629 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013959402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | G77927 (California) | Primary |
| Provider Name | Thanh T Le |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1134165350 PECOS PAC ID: 6709972268 Enrollment ID: I20080616000412 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
| Provider Name | Mary K Dyes |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1891737219 PECOS PAC ID: 3072609536 Enrollment ID: I20111215000470 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
| Provider Name | Jean L Lake |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1386686673 PECOS PAC ID: 2264528728 Enrollment ID: I20111228000248 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
| Provider Name | Nicole H Cobo |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1497954119 PECOS PAC ID: 1254566771 Enrollment ID: I20131108000381 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
| Provider Name | Jasmin Dao |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1164811568 PECOS PAC ID: 8022397447 Enrollment ID: I20200303002789 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in the study.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
The Guardian reports, as part of an online feature about health care workforces worldwide done in association with the Global Health Workforce Alliance (GHWA), that "Africa is desperately short of doctors and nurses. So is much of Asia. In 57 countries, the situation is deemed by the World Health Organisation (WHO) to be at crisis point ... But in contrast to some other developing world problems, this is an issue that really does affect all of us. The world needs an estimated 4.2 million more health workers."
› Verified 7 days ago
Helpline Youth Counseling, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1133 Rhea St, Long Beach, CA 90806 Phone: 562-599-2244 Fax: 562-946-3641 | |
Mental Health America Of Los Angeles Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Pine Ave Ste 400, Long Beach, CA 90802 Phone: 562-285-1330 Fax: 562-263-3395 | |
Long Beach Family Recovery Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 514 W Pacific Coast Hwy, Long Beach, CA 90806 Phone: 310-679-9126 Fax: 310-679-2920 | |
Julie Goalwin, Ph.d. A Psychological Corporation Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 115 Pine Ave Ste 640, Long Beach, CA 90802 Phone: 562-364-8587 Fax: 562-364-8588 | |
In The Meantime Breathe Family Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4401 Atlantic Ave Ste 229, Long Beach, CA 90807 Phone: 310-220-9631 | |
Silvan Medical Consulting, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2776 Pacific Ave, Long Beach, CA 90806 Phone: 949-288-5377 Fax: 774-209-4466 | |
Pride Detox Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3805 E 15th St, Long Beach, CA 90804 Phone: 866-465-6889 Fax: 561-671-7512 |